Eric Deutsch, MD, PhD is a Professor in Oncology and Radiotherapy at Université Paris-Saclay, a position he has held since 2010, Director of Inserm Molecular Radiotherapy and Novel therapeutic innovation UMR1030, a position he has held since 2012, and Chair of the Radiation Oncology Department at Gustave Roussy Cancer Campus, a position he has held since 2012. Prof. Deutsch trained as a Radiation Oncologist at Paris-Diderot University. He gained a PhD degree in the fundamental basis of oncogenesis in 2003 at South Paris University XI, and completed his training with a post-doctoral fellowship in the Radiation Oncology Department, at the University of Pennsylvania, United States. Prof. Deutsch became a tenure-track and full time cancer specialist at Gustave Roussy Cancer Campus in 2006. With a strong background in research, he leads several clinical trials translating innovative approaches into the clinic, namely in the field of radiation therapy and immunotherapies. He is currently Head of the RHU LYSAIRI Project, and manages more than 150 people in clinic and research, under his leadership. Prof. Deutsch is a board member of the Gustave Roussy transfer office and is well versed in transfer, valorization and contracting aspects of research. He is also involved in the Early Drug Development Department (DITEP) at Gustave Roussy. Prof. Deutsch has contributed to over 250 peer-reviewed publications. He is a member of the Editorial Board for the ESTRO journal in Radiotherapy and Oncology. His fields of expertise includes early clinical trials and phase I, macrophages and immunotherapy, radiomics and artificial intelligence, novel anticancer drugs, radiation biology, HPVs related tumors, combination with new drugs and radiotherapy.